These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 8410287

  • 1. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy.
    Hoekstra OS, Ossenkoppele GJ, Golding R, van Lingen A, Visser GW, Teule GJ, Huijgens PC.
    J Nucl Med; 1993 Oct; 34(10):1706-10. PubMed ID: 8410287
    [Abstract] [Full Text] [Related]

  • 2. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
    Okada J, Yoshikawa K, Imazeki K, Minoshima S, Uno K, Itami J, Kuyama J, Maruno H, Arimizu N.
    J Nucl Med; 1991 Apr; 32(4):686-91. PubMed ID: 2013808
    [Abstract] [Full Text] [Related]

  • 3. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C, Reman O, Henry-Amar M, Peny AM, Macro M, Cheze S, Génot JY, Tanguy A, Switsers O, Van HL, Couëtte JE, Leporrier M, Bardet S.
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.
    Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Lorenz WJ, Maier-Borst W, van Kaick G.
    Eur J Nucl Med; 1995 May; 22(5):434-42. PubMed ID: 7641752
    [Abstract] [Full Text] [Related]

  • 5. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma.
    Paul R.
    J Nucl Med; 1987 Mar; 28(3):288-92. PubMed ID: 3469332
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography.
    Hoekstra OS, van Lingen A, Ossenkoppele GJ, Golding R, Teule GJ.
    Eur J Nucl Med; 1993 Dec; 20(12):1214-7. PubMed ID: 8299657
    [Abstract] [Full Text] [Related]

  • 9. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
    Israel O, Mekel M, Bar-Shalom R, Epelbaum R, Hermony N, Haim N, Dann EJ, Frenkel A, Ben-Arush M, Gaitini D.
    J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
    [Abstract] [Full Text] [Related]

  • 10. Ga-67 SPECT before and after treatment of lymphoma.
    Front D, Israel O, Epelbaum R, Ben Haim S, Sapir EE, Jerushalmi J, Kolodny GM, Robinson E.
    Radiology; 1990 May; 175(2):515-9. PubMed ID: 2183289
    [Abstract] [Full Text] [Related]

  • 11. The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment.
    Bar-Shalom R, Mor M, Yefremov N, Goldsmith SJ.
    Semin Nucl Med; 2001 Jul; 31(3):177-90. PubMed ID: 11430525
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Residual mass and negative gallium scintigraphy in treated lymphoma.
    Israel O, Front D, Epelbaum R, Ben-Haim S, Jerushalmi J, Kleinhaus U, Even-Sapir E, Robinson E.
    J Nucl Med; 1990 Mar; 31(3):365-8. PubMed ID: 2308008
    [Abstract] [Full Text] [Related]

  • 16. Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care.
    Kaplan LD.
    Am J Med; 2002 Mar; 112(4):320-1. PubMed ID: 11893374
    [No Abstract] [Full Text] [Related]

  • 17. The continuing clinical role of gallium 67 scintigraphy in the age of receptor imaging.
    Front D, Bar-Shalom R, Israel O.
    Semin Nucl Med; 1997 Jan; 27(1):68-74. PubMed ID: 9122725
    [Abstract] [Full Text] [Related]

  • 18. [Positron emission tomography of the thorax. The current clinical status].
    Knopp MV, Bischoff H, Oberdorfer F, van Kaick G.
    Radiologe; 1992 Jun; 32(6):290-5. PubMed ID: 1641486
    [Abstract] [Full Text] [Related]

  • 19. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.
    Mouratidis B, Gilday DL, Ash JM.
    Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402
    [Abstract] [Full Text] [Related]

  • 20. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity.
    Okada J, Yoshikawa K, Itami M, Imaseki K, Uno K, Itami J, Kuyama J, Mikata A, Arimizu N.
    J Nucl Med; 1992 Mar; 33(3):325-9. PubMed ID: 1740697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.